Works matching AU Migkou, Magdalini

Results: 93
    1

    Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 4, p. 725, doi. 10.1002/hon.3135
    By:
    • Theodorakakou, Foteini;
    • Briasoulis, Alexandros;
    • Fotiou, Despina;
    • Petropoulos, Ioannis;
    • Georgiopoulos, Georgios;
    • Lama, Niki;
    • Kelekis, Nikolaos;
    • Repasos, Evangelos;
    • Migkou, Magdalini;
    • Stamatelopoulos, Kimon;
    • Dimopoulos, Meletios A;
    • Kastritis, Efstathios
    Publication type:
    Article
    2

    Thrombotic and bleeding complications in patients with AL amyloidosis.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 1816, doi. 10.1111/bjh.19331
    By:
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Sotiria;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Malandrakis, Panagiotis;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    3

    Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab‐based therapy.

    Published in:
    British Journal of Haematology, 2023, v. 203, n. 3, p. 411, doi. 10.1111/bjh.19042
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Papanikolaou, Asimina;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    4

    Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 2, p. 356, doi. 10.1111/bjh.17841
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Malandrakis, Panagiotis;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Fotiou, Despina;
    • Papanagnou, Eleni‐Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis P.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios‐Athanasios
    Publication type:
    Article
    5

    Daratumumab‐based therapy for patients with monoclonal gammopathy of renal significance.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 1, p. 113, doi. 10.1111/bjh.17052
    By:
    • Kastritis, Efstathios;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Psimenou, Erasmia;
    • Gakiopoulou, Charikleia;
    • Marinaki, Smaragdi;
    • Gatou, Anastasia;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Malandrakis, Panagiotis;
    • Dialoupi, Ioanna;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Kostopoulos, Ioannis V.;
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    6

    Response of an oncology unit in the midst of the COVID-19 outbreak.

    Published in:
    Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 8, p. 1947, doi. 10.1177/1078155220967973
    By:
    • Liontos, Michalis;
    • Kastritis, Efstathios;
    • Migkou, Magdalini;
    • Koutsoukos, Konstantinos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Psaltopoulou, Theodora;
    • Zagouri, Flora;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    Article
    7

    Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine.

    Published in:
    Clinical & Experimental Medicine, 2022, v. 22, n. 2, p. 319, doi. 10.1007/s10238-021-00746-4
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Ntanasis-Stathopoulos, Ioannis;
    • Sklirou, Aimilia D.;
    • Malandrakis, Panagiotis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Migkou, Magdalini;
    • Trougakos, Ioannis P.;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    8

    Emerging treatment strategies for COVID-19 infection.

    Published in:
    Clinical & Experimental Medicine, 2021, v. 21, n. 2, p. 167, doi. 10.1007/s10238-020-00671-y
    By:
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Korompoki, Eleni;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Tzanninis, Ioannis-Georgios;
    • Psaltopoulou, Theodora;
    • Kastritis, Efstathios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    9

    Increased serum B‐cell maturation antigen levels evaluated with an Elecsys‐based serum B‐cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma.

    Published in:
    EJHaem, 2025, v. 6, n. 1, p. 1, doi. 10.1002/jha2.889
    By:
    • Terpos, Evangelos;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis‐Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Dimopoulos, Meletios A;
    • Kastritis, Efstathios
    Publication type:
    Article
    10

    ciRS‐7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma.

    Published in:
    EJHaem, 2024, v. 5, n. 4, p. 677, doi. 10.1002/jha2.903
    By:
    • Papatsirou, Maria;
    • Kontos, Christos K.;
    • Ntanasis‐Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Theodorakakou, Foteini;
    • Liacos, Christine‐Ivy;
    • Mavrianou‐Koutsoukou, Nefeli;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Scorilas, Andreas;
    • Terpos, Evangelos
    Publication type:
    Article
    11

    Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in Greece.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 468, doi. 10.1016/j.clml.2024.03.003
    By:
    • Kastritis, Efstathios;
    • Ntanasis-Stathopoulos, Ioannis;
    • Theodorakakou, Foteini;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Fotiou, Despina;
    • Spiliopoulou, Vassiliki;
    • Gavriatopoulou, Maria;
    • Patel, Sachin;
    • Majer, Istvan;
    • Boukis, Christos;
    • Fetani, Andriani;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    12

    Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 11, p. 844, doi. 10.1016/j.clml.2023.07.013
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Solia, Eirini;
    • Theodorakakou, Foteini;
    • Spiliopoulou, Vasiliki;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Migkou, Magdalini;
    • Kokkali, Nikoleta;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Syrigou, Rodanthi;
    • Fotiou, Despina;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    13

    P-209: High response rates with IMiD retreatment post anti-CD38 exposure in patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S154, doi. 10.1016/S2152-2650(21)02336-3
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    14

    P-127: Patients with Multiple Myeloma on treatment with Anti-CD38 or Anti-BCMA agents have a suboptimal humoral response following COVID-19 vaccination.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S104, doi. 10.1016/S2152-2650(21)02254-0
    By:
    • Terpos, Evangelos;
    • Gavriatopoulou, Maria;
    • Ntanasis-Stathopoulos, Ioannis;
    • Briasoulis, Alexandros;
    • Gumeni, Sentiljana;
    • Malandrakis, Panagiotis;
    • Fotiou, Despina;
    • Papanagnou, Eleni-Dimitra;
    • Migkou, Magdalini;
    • Theodorakakou, Foteini;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kanellias, Nikolaos;
    • Trougakos, Ioannis;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios
    Publication type:
    Article
    15

    Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma.

    Published in:
    2020
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Gika, Dimitra;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios C.;
    • Ntanasis-Stathopoulos, Ioannis;
    • Mparmparousi, Despoina;
    • Gatou, Anastasia;
    • Katopi, Despina;
    • Manios, Efstathios;
    • Liontos, Michail;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article
    16

    Screening for Gaucher disease in patients with plasma cell dyscrasias.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e327, doi. 10.1016/j.clml.2019.09.537
    By:
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    17

    Primary Treatment of Light Chain (AL) Amyloidosis With Bortezomib, Lenalidomide and Dexamethasone (VRD) or with Bortezomib, Cyclophosphamide and Dexamethasone (VCD/CyBorD): efficacy and toxicity.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e320, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Tselegkidi, Maria Irini;
    • Marinaki, Smaragdi;
    • Psimenou, Erasmia;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gakiopoulou, Harikleia;
    • Papanota, Aristea-Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    18

    Flow-Mediated Dilatation (FMD) and Aortic Blood Pressure May Predict Cardiovascular Adverse Events During Carfilzomib Therapy: A Prospective Study in Relapsed/Refractory Multiple Myeloma Patients.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e262, doi. 10.1016/j.clml.2019.09.433
    By:
    • Kastritis, Efstathios;
    • Laina, Aggeliki;
    • Gavriatopoulou, Maria;
    • Georgiopoulos, Georgios;
    • Fotiou, Despina;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Makris, Nikolaos;
    • Papanota, Aristea-Maria;
    • Trougakos, Ioannis P.;
    • Kotsopoulou, Maria;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Terpos, Evangelos;
    • Stamatelopoulos, Kimon;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    19

    Longitudinal Evaluation of Minimal Residual Disease in Patients with Multiple Myeloma who Achieve Complete Response After First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e185, doi. 10.1016/j.clml.2019.09.310
    By:
    • Kostopoulos, Ioannis V.;
    • Kastritis, Efstathios;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    20

    Absence of Aberrant Plasma Cells in the Apheresis Product Predicts for Minimal Residual Disease Negativity after Autologous Transplantation in Myeloma Patients Who Receive First Line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e184, doi. 10.1016/j.clml.2019.09.309
    By:
    • Terpos, Evangelos;
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanota, Aristea-Maria;
    • Micheli, Paraskevi;
    • Malandrakis, Panagiotis;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Liacos, Christine-Ivy;
    • Gavriatopoulou, Maria;
    • Kastritis, Efstathios;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    21

    Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S331, doi. 10.1016/j.clml.2019.07.322
    By:
    • Kastritis, Efstathios;
    • Dialoupi, Ioanna;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papadopoulou, Elektra;
    • Ziogas, Dimitrios C.;
    • Stamatelopoulos, Kimon;
    • Manios, Efstathios;
    • Ntalianis, Argyrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Migkou, Magdalini;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Tselegkidi, Marini;
    • Tsitsilonis, Ourania;
    • Trougakos, Ioannis
    Publication type:
    Article
    22

    Incidence of Skeletal-Related Events at Diagnosis and at the Time of First Relapse in 463 Patients with Multiple Myeloma Who Received First Line Treatment in a Single Center.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S333, doi. 10.1016/j.clml.2019.07.325
    By:
    • Terpos, Evangelos;
    • Kanellias, Nikolaos;
    • Moulopoulos, Lia A.;
    • Christoulas, Dimitrios;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Bagratuni, Tina;
    • Koutoulidis, Vasilios;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    23

    Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma who Are Treated with Bortezomib-Based Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S325, doi. 10.1016/j.clml.2019.07.310
    By:
    • Papanota, Aristea-Maria;
    • Kastritis, Efstathios;
    • Papassotiriou, Gerasimos-Petros;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Margeli, Alexandra;
    • Migkou, Magdalini;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gavriatopoulou, Maria;
    • Psimenou, Erasmia;
    • Papassotiriou, Ioannis;
    • Dimopoulos, Meletios A.;
    • Terpos, Evangelos
    Publication type:
    Article
    24

    Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.

    Published in:
    2019
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Papasotiriou, Ioannis;
    • Fotiou, Despoina;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Ziogas, Dimitrios;
    • Dialoupi, Ioanna;
    • Eleutherakis Papaiakovou, Evangelos;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios Athanasios
    Publication type:
    journal article
    25
    26

    Outcomes of Consecutive Patients With Newly Diagnosed Myeloma Requiring Dialysis: Dialysis Independence is Associated with Rapid Myeloma Response and Predicts for Longer Survival.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e62, doi. 10.1016/j.clml.2017.03.114
    By:
    • Dimopoulos, Meletios Athanasios;
    • Pouli, Anastasia;
    • Roussou, Maria;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Psimenou, Erasmia;
    • Matsouka, Charis;
    • Mparmparousi, Despoina;
    • Giannouli, Stavroula;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article
    27
    28

    Bortezomib and Lenalidomide (VR) Consolidation Post-ASCT without Dexamethasone and Bisphosphonates: Final Analysis of a Prospective Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e143, doi. 10.1016/j.clml.2017.03.259
    By:
    • Terpos, Evangelos;
    • Kastritis, Efstathios;
    • Christoulas, Dimitrios;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Fotiou, Despina;
    • Panagiotidis, Ioannis;
    • Ziogas, Dimitrios C.;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    29

    Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients With AL amyloidosis Treated With Bortezomib.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e65, doi. 10.1016/j.clml.2017.03.119
    By:
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Ziogas, Dimitrios C.;
    • Fotiou, Despina;
    • Migkou, Magdalini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Panagiotidis, Ioannis;
    • Kanellias, Nikolaos;
    • Psimenou, Erasmia;
    • Papadopoulou, Elektra;
    • Pamboucas, Constatntinos;
    • Gakiopoulou, Harikleia;
    • Tasidou, Anna;
    • Giannouli, Stavroula;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Article
    30

    Prior Lenalidomide Resistance and the Impact of IMiD-free Interval in Patients Treated with Pomalidomide and Dexamethasone.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e115, doi. 10.1016/j.clml.2017.03.210
    By:
    • Dimopoulos, Meletios Athanasios;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Panagiotidis, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ziogas, Dimitrios C.;
    • Fotiou, Despina;
    • Giannouli, Stavroula;
    • Tsirigotis, Panagiotis;
    • Mparmparousi, Despoina;
    • Matsouka, Charis;
    • Delimpasi, Sossana;
    • Terpos, Evangelos;
    • Kastritis, Efstathios
    Publication type:
    Article
    31
    32
    33
    34
    35

    Angiogenesis in Waldenström's Macroglobulinemia.

    Published in:
    Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 46
    By:
    • Terpos, Evangelos;
    • Tasidou, Anna;
    • Kastritis, Efstathios;
    • Eleftherakis-Papaiakovou, Evangelos;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Dimopoulos, Meletios-Athanassios
    Publication type:
    Article
    36

    Rituximab-Based Treatments in Waldenström's Macroglobulinemia.

    Published in:
    Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 59
    By:
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Tassidou, Anna;
    • Terpos, Evangelos
    Publication type:
    Article
    37

    Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies.

    Published in:
    2025
    By:
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Spiliopoulou, Vasiliki;
    • Migkou, Magdalini;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Solia, Eirini;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Courraud, Julie;
    • Nikolaou, Panagiota-Efstathia;
    • Giannouli, Stavroula;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • Kastritis, Efstathios
    Publication type:
    Letter to the Editor
    38

    Pulmonary function tests reveal unrecognised lung dysfunction and have independent prognostic significance in patients with systemic AL amyloidosis.

    Published in:
    Amyloid, 2023, v. 30, n. 2, p. 153, doi. 10.1080/13506129.2022.2136519
    By:
    • Trakada, Georgia;
    • Fotiou, Despina;
    • Kallianos, Anastasios;
    • Theodorakakou, Foteini;
    • Migkou, Magdalini;
    • Gavriatopoulou, Maria;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Dialoupi, Ioanna;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.;
    • Kastritis, Efstathios
    Publication type:
    Article
    39

    Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease.

    Published in:
    Amyloid, 2021, v. 28, n. 4, p. 259, doi. 10.1080/13506129.2021.1971192
    By:
    • Kastritis, Efstathios;
    • Rousakis, Pantelis;
    • Kostopoulos, Ioannis V.;
    • Gavriatopoulou, Maria;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Dialoupi, Ioanna;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Kanellias, Nikolaos;
    • Tselegkidi, Maria-Irini;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papanikolaou, Asimina;
    • Gakiopoulou, Charikleia;
    • Psimenou, Erasmia;
    • Spyropoulou-Vlachou, Marylin;
    • Gatou, Anastasia;
    • Terpos, Evangelos;
    • Tsitsilonis, Ourania;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    40

    Next generation flow cytometry for MRD detection in patients with AL amyloidosis.

    Published in:
    Amyloid, 2021, v. 28, n. 1, p. 19, doi. 10.1080/13506129.2020.1802713
    By:
    • Kastritis, Esftathios;
    • Kostopoulos, Ioannis V.;
    • Theodorakakou, Foteini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Migkou, Magdalini;
    • Tselegkidi, Maria Irini;
    • Roussou, Maria;
    • Papathoma, Alexandra;
    • Eleutherakis-Papaioakovou, Evangelos;
    • Dialoupi, Ioanna;
    • Kanellias, Nikolaos;
    • Ntalianis, Argyrios;
    • Rousakis, Pantelis;
    • Trougakos, Ioannis P.;
    • Tsitsilonis, Ourania;
    • Gakiopoulou, Charikleia;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    41

    Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis.

    Published in:
    Amyloid, 2021, v. 28, n. 1, p. 3, doi. 10.1080/13506129.2020.1798224
    By:
    • Kastritis, Efstathios;
    • Fotiou, Despina;
    • Theodorakakou, Foteini;
    • Dialoupi, Ioanna;
    • Migkou, Magdalini;
    • Roussou, Maria;
    • Karatrasoglou, Eleni A.;
    • Tselegkidi, Maria Irini;
    • Ntalianis, Argyrios;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Gakiopoulou, Charikleia;
    • Papanikolaou, Asimina;
    • Papathoma, Alexandra;
    • Spyropoulou-Vlachou, Marylin;
    • Psimenou, Erasmia;
    • Stamatelopoulos, Kimon;
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos
    Publication type:
    Article
    42

    Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis.

    Published in:
    Amyloid, 2018, v. 25, n. 4, p. 234, doi. 10.1080/13506129.2018.1540410
    By:
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Roussou, Maria;
    • Bagratuni, Tina;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Kanellias, Nikolaos;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Dialoupi, Ioanna;
    • Ntanasis-Stathopoulos, Ioannis;
    • Spyropoulou-Vlachou, Mairylin;
    • Psimenou, Erasmia;
    • Gakiopoulou, Harikleia;
    • Marinaki, Smaragdi;
    • Papadopoulou, Elektra;
    • Ntalianis, Argyrios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article
    43

    Aberrant Plasma Cell Contamination of Peripheral Blood Stem Cell Autografts, Assessed by Next-Generation Flow Cytometry, Is a Negative Predictor for Deep Response Post Autologous Transplantation in Multiple Myeloma; A Prospective Study in 199 Patients.

    Published in:
    Cancers, 2021, v. 13, n. 16, p. 4047, doi. 10.3390/cancers13164047
    By:
    • Kostopoulos, Ioannis V.;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Rousakis, Pantelis;
    • Ntanasis-Stathopoulos, Ioannis;
    • Panteli, Chrysanthi;
    • Orologas-Stavrou, Nikolaos;
    • Kanellias, Nikolaos;
    • Malandrakis, Panagiotis;
    • Liacos, Christine-Ivy;
    • Papaioannou, Nikos E.;
    • Papanota, Aristea-Maria;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Gavriatopoulou, Maria;
    • Angelis, Nikolaos V.;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios-Athanasios;
    • Tsitsilonis, Ourania E.;
    • Terpos, Evangelos
    Publication type:
    Article
    44

    Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit.

    Published in:
    Cancers, 2021, v. 13, n. 4, p. 763, doi. 10.3390/cancers13040763
    By:
    • Liontos, Michalis;
    • Kastritis, Efstathios;
    • Markellos, Christos;
    • Migkou, Magdalini;
    • Eleftherakis-Papaiakovou, Evangelos;
    • Koutsoukos, Konstantinos;
    • Gavriatopoulou, Maria;
    • Zagouri, Flora;
    • Psaltopoulou, Theodora;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios-Athanasios;
    • D'Orazi, Gabriella;
    • Cirone, Mara
    Publication type:
    Article
    45
    46
    47

    Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome.

    Published in:
    2019
    By:
    • Trakada, Georgia;
    • Kastritis, Efstathios;
    • Gavriatopoulou, Maria;
    • Velentza, Lemonia;
    • Fotiou, Despina;
    • Ziogas, Dimitrios C.;
    • Panagiotidis, Ioannis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Roussou, Maria;
    • Migkou, Magdalini;
    • Kanellias, Nikolaos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Kallianos, Anastasios;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    journal article
    48

    Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma

    Published in:
    2020
    By:
    • Gavriatopoulou, Maria;
    • Terpos, Evangelos;
    • Ntanasis-Stathopoulos, Ioannis;
    • Malandrakis, Panagiotis;
    • Eleutherakis-Papaiakovou, Evangelos;
    • Papatheodorou, Athanasios;
    • Kanellias, Nikolaos;
    • Migkou, Magdalini;
    • Fotiou, Despina;
    • Dialoupi, Ioanna;
    • Roussou, Maria;
    • Kokkali, Nikoletta-Aikaterini;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.
    Publication type:
    Letter
    49
    50

    High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients.

    Published in:
    British Journal of Haematology, 2010, v. 150, n. 5, p. 587, doi. 10.1111/j.1365-2141.2010.08288.x
    By:
    • Kastritis, Efstathios;
    • Roussou, Maria;
    • Michael, Michalis;
    • Gavriatopoulou, Maria;
    • Michalis, Evridiki;
    • Migkou, Magdalini;
    • Delimpasi, Sossana;
    • Kyrtsonis, Marie Christine;
    • Gogos, Dimitrios;
    • Liapis, Konstantinos;
    • Charitaki, Evangelia;
    • Repousis, Panagiotis;
    • Terpos, Evangelos;
    • Dimopoulos, Meletios A.
    Publication type:
    Article